Friday, 26 January 2018

FDA clears radioactive drug for cancer that killed Steve Jobs

(Reuters) - The U.S. Food and Drug Administration on Thursday approved a radioactive drug to treat the ultra-rare type of digestive tract cancer that killed Steve Jobs in 2011.


No comments:

Post a Comment